[Regulation]Regulation update: EU Ban on 2,4-DNT in Automotive Safety Parts (Regulation EU 2026/859)

22 Apr 2026


74f96d42c0884.png


We would like to inform you of the key details of Commission Regulation (EU) 2026/859, published in the Official Journal of the European Union on April 21, 2026. 

The core of this regulation is the phase-out of a specific carcinogen (2,4-DNT) from imported articles such as automotive airbags and seat belts from the EU market, which requires proactive measures from parts export companies.



Overview 

"2,4-DNT (CAS No. 121-14-2)" is an officially designated Category 1B carcinogen by the EU. It is a hazardous substance that can have fatal effects on the human body even in very small amounts, to the extent that it is impossible to establish a Derived No-Effect Level (DNEL) for cancer risks. The EU already practically banned the use of this substance within its territory as of August 21, 2015. 

However, this restriction did not apply to articles manufactured outside the EU and imported into the region. To close this regulatory loophole, the European Chemicals Agency (ECHA) launched a comprehensive investigation and confirmed that 2,4-DNT is detected in various imported articles, including airbags, seat belts, and refractory materials. This new regulation is the result published to completely block this gap.



Key Takeaways 

1. Ban Criteria and Exemptions 

Starting May 10, 2027, the distribution of articles containing "2,4-DNT" in a concentration equal to or greater than 0.1% by weight will be strictly prohibited in the EU market. 

However, the following items are exempt from the regulation:

*Note: Pyrotechnic articles such as fireworks and civilian ammunition do not fall under the above exemptions and are subject to the regulation.


2. Automotive Industry Changes 

A 36-month grace period is granted for certain automotive parts, meaning the regulation will apply from May 11, 2029.

 Exempted Parts 

  • Seat belt pretensioners

  • Micro gas generators for bonnet actuators

  • Spare parts


Transitional Measures

Timeline & TargetApplied Measures 
Vehicles placed on the EU market before May 10, 2027
Completely excluded from the regulation
Vehicles launched between May 10, 2027 ~ May 11, 2029

Conditional exemption applied

(The use of the substance is allowed only in the specified parts under the grace period, and operation is permitted until the end of the vehicle's life cycle)


3. IMDS Practical Impact

  • Transition to Prohibited (P) Substance: "2,4-DNT" was previously a 'Declarable (D)' target when exceeding 0.1%. However, it will transition to a 'Prohibited (P)' status starting May 10, 2027. Parts registered with this substance above the threshold limit cannot be exported to the EU.

  • Practical Inspection: We recommend verifying the constituent materials of pyrotechnic parts (propellants, gas generants) within airbag initiators and seat belt pretensioners.

According to ECHA, alternatives exist for all uses, so we advise EU export companies to restructure their supply chains and pre-check their IMDS data.



Conclusion 

This regulation enters into force on May 11, 2026, and practical distribution restrictions will apply from 2027 for general parts and 2029 for automotive safety parts. 

As the regulation of carcinogens in imported articles has begun in earnest, we encourage you to establish a comprehensive inspection of related parts and a plan for transitioning to alternative materials.


MDSKorea will continue to do its best to provide useful regulatory insights for professionals. Thank you.





[References & Links]



MDSKorea Inc. 

Head Office: 314, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

Seoul Office: Digital-ro 26-gil, Guro-gu, Seoul, Korea 

Incheon Office : 22, Inha-ro 489-beon-gil, Namdong-gu, Incheon, Korea 


Copyright ⓒ 2026 MDSKorea Inc. All Rights Reserved

Business Registration No.: 142-81-81626 | E-commerce Registration No.: 2024-YonginSuji-1885 

Representative: Yongyeon Hwang


Request a Consultation

Have questions about our services? 

Submit your inquiry, and our team will get back to you promptly.

MDSKorea Inc.

  Head Office

314, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

  Seoul Office

173, Digital-ro, Geumcheon-gu, Seoul, Korea 

  Incheon Office

22, Inha-ro 489beon-gil, Namdong-gu, Incheon, Korea 

ⓒ 2023 MDSKorea Inc. All Rights Reserved